BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Treatment
6 results:

  • 1. Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
    Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
    Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. p53 Pathway Inactivation Drives smarcb1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition.
    Oppel F; Shao S; Gendreizig S; Zimmerman MW; Schürmann M; Flavian VF; Goon P; Chi SN; Aster JC; Sudhoff H; Look AT
    Mol Cancer Ther; 2022 Nov; 21(11):1689-1700. PubMed ID: 36099437
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer.
    Stachowiak M; Szymanski M; Ornoch A; Jancewicz I; Rusetska N; Chrzan A; Demkow T; Siedlecki JA; Sarnowski TJ; Sarnowska E
    IUBMB Life; 2020 Jun; 72(6):1175-1188. PubMed ID: 32073734
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors.
    Rooper LM; Bishop JA; Westra WH
    Am J Surg Pathol; 2018 May; 42(5):665-671. PubMed ID: 29438167
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary.
    Shih J; Bashir B; Gustafson KS; Andrake M; Dunbrack RL; Goldstein LJ; Boumber Y
    J Natl Compr Canc Netw; 2015 Aug; 13(8):947-52. PubMed ID: 26285240
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Head and neck manifestations of 22q11.2 deletion syndromes.
    Marom T; Roth Y; Goldfarb A; Cinamon U
    Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):381-7. PubMed ID: 21861138
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.